Category: type II endoleak

Pivotal study of TripleMed’s AneuFix device for type II endoleak enrols first 13 patients

TripleMed BV recently announced an enrolment update regarding the pivotal clinical study of the company’s AneuFix product for the treatment of type II endoleaks. According to a TripleMed press release, 13 patients have been successfully treated with AneuFix without any major complications. The company plans to enrol a total of 25 patients across six hospitals […]

The post Pivotal study of TripleMed’s AneuFix device for type II endoleak enrols first 13 patients appeared first on Vascular News.